Brief: Innoviva To Acquire Entasis Therapeutics

Innoviva

23/05/2022 13:52

May 23 (Reuters) - Entasis Therapeutics Holdings Inc
 ETTX.O :
    * INNOVIVA TO ACQUIRE ENTASIS THERAPEUTICS
    * ENTASIS THERAPEUTICS HOLDINGS INC - PROPOSED DEAL FOR
$2.20 PER
SHARE IN CASH
    * ENTASIS THERAPEUTICS HOLDINGS INC - PROPOSED DEAL FOR
INNOVIVA
CURRENTLY OWNS APPROXIMATELY 60% OF OUTSTANDING SHARES OF
ENTASIS
    * ENTASIS THERAPEUTICS HOLDINGS INC - ACQUISITION
CONSIDERATION
VALUES ENTASIS' EQUITY AT $113 MILLION ON A FULLY DILUTED BASIS
    * ENTASIS THERAPEUTICS HOLDINGS INC - TRANSACTION HAS BEEN
UNANIMOUSLY APPROVED BY INNOVIVA AND ENTASIS BOARDS OF DIRECTORS

Source text for Eikon:  ID:nBw1DpHqha 
Further company coverage:  ETTX.O 

 ((Reuters.Briefs@thomsonreuters.com;))